Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA10 - Updates in Thymoma

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      Session Moderator

      15:22 - 15:27  |  Presenter: Noboru Yamamoto

      • Abstract

      Loading...

    • +

      Session Moderator

      15:22 - 15:27  |  Presenter: Paul J Van Houtte

      • Abstract

      Loading...

    • +

      MA10.01 - Session Introduction

      14:45 - 14:46  |  Presenter: Noboru Yamamoto

      • Abstract

      Loading...

    • +

      MA10.02 - Session Introduction

      14:46 - 14:47  |  Presenter: Paul J Van Houtte

      • Abstract

      Loading...

    • +

      MA10.03 - Is Thoracoscopic Thymectomy Safe and Oncologically Sound in Large Thymic Tumors?

      14:47 - 14:52  |  Presenter: Karthik Venkataramani

      • Abstract

      Loading...

    • +

      MA10.04 - Long-term Follow-up Study of Thymic Epithelial Tumors. Report of the Updated Nation-wide Database in Japan

      14:52 - 14:57  |  Presenter: Meinoshin Okumura

      • Abstract

      Loading...

    • +

      MA10.05 - High Levels of CD47 Expression in Thymic Epithelial Tumors

      14:57 - 15:02  |  Presenter: Thomas Yang Sun

      • Abstract

      Loading...

    • +

      MA10.06 - Discussant

      15:02 - 15:12  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      Loading...

    • +

      MA10.07 - Phase II Trial of Sunitinib in Patients with Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines - STYLE Trial (NCT03449173)

      15:12 - 15:17  |  Presenter: Claudia Proto

      • Abstract

      Loading...

    • +

      MA10.08 - Activated Pathways of Myastenia Gravis in Thymic Epithelial (TETs)

      15:17 - 15:22  |  Presenter: Jose Carlos Benítez

      • Abstract

      Loading...

    • +

      MA10.09 - Outcomes of Induction Therapy Followed by Surgical Resection for Advanced Thymic Tumor

      15:22 - 15:27  |  Presenter: Sumin Shin

      • Abstract

      Loading...

    • +

      MA10.10 - Discussant

      15:27 - 15:37  |  Presenter: Alessandra Curioni-Fontecedro

      • Abstract

      Loading...

    • +

      MA10.11 - Live Q&A

      15:37 - 15:45

      • Abstract

      Loading...